Related Experiment Videos
Different aetiology of chronic active hepatitis in U.K. and Iraq
Insights
Chronic active hepatitis differs significantly between Iraq and the UK, primarily due to hepatitis B virus (HBV) infection rates. Iraqi patients often had advanced cirrhosis, while UK patients showed more acute symptoms and autoimmune features.
Area of Science:
- Hepatology
- Immunology
- Clinical Medicine
Background:
- Chronic active hepatitis presents diverse clinical, biochemical, and immunological characteristics globally.
- Hepatitis B virus (HBV) infection is a major etiological factor in chronic liver disease worldwide.
- Geographical variations in hepatitis prevalence and autoimmune conditions influence disease presentation.
Purpose of the Study:
- To compare clinical, biochemical, and immunological features of chronic active hepatitis patients from Iraq and the United Kingdom.
- To investigate the impact of geographical location and etiological factors on disease presentation and progression.
- To identify key differences in disease manifestations and associated conditions between the two patient cohorts.
Main Methods:
- Biopsy-proven chronic active hepatitis patients from Iraq and the UK were recruited.
- Clinical, biochemical, and immunological data were collected and compared between the two groups.
- Hepatitis B surface antigen (HBsAg) status was assessed as a primary etiological factor.
Main Results:
- A significant difference in HBV status was observed: 91% of Iraqi patients were HBsAg-positive versus 6% of UK patients.
- Iraqi patients predominantly presented with insidious onset and established cirrhosis.
- UK patients more frequently exhibited acute presentation, systemic symptoms, autoantibodies, and autoimmune conditions.
Conclusions:
- Hepatitis B virus infection is the main driver of differences in chronic active hepatitis between Iraq and the UK.
- Geographical variations significantly impact the clinical presentation and immunological profile of chronic active hepatitis.
- Understanding these differences is crucial for targeted diagnosis and management strategies in diverse populations.
Abstract:
We have compared the clinical, biochemical and immunological features of patients with biopsy-proven chronic active hepatitis from Iraq and from the United Kingdom. Clear-cut differences emerge, which can mostly be attributed to the HBV status, as 91% of patients from Iraq were HBsAg-positive compared to only 6% from the U.K. Most patients from Iraq presented insidiously with established cirrhosis, while those from the U.K. presented more acutely and systemic symptoms were more common. Autoantibodies and associated autoimmune conditions were common in U.K. patients but extremely rare in Iraqis.